|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia显示文摘 | Dujovne CA Zavoral JH Rowe E eta l | 2001 | Am Heart J2001，142，3： | 1 |
| 2 | Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia显示文摘 | Dujovne CA Ettinger MP McNeer JF | 2002 | Am J Cardiol2002，90，10： | 1 |
| 3 | Evaluation of the efficacy,safety,and tolerability of ezetimibe in primary hypercholesterolaemia:a pooled analysis from two controlled phase Ⅲclinical studies显示文摘 | KNOPP R H DUJOVNE C A LE BEAUT A | 2003 | Int J Clin Pract2003，57，5： | 1 |
| 4 | Inhibiting cholesterol absorption with CP-88, 818 (beta-tigogenin cellobioside; tiqueside): studies in normal and hyperlipidemic subjects 显示文摘 | Harris W S Dujovne C A Windsor S L | 1997 | J Cardiovasc Phar- macol1997，30，1： | 1 |
| 5 | Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies显示文摘 | Knopp RH Dujovne CA Le Beaut A | 2003 | Int J Clin Pract2003，57，5： | 1 |
| 6 | Colesevelam HCh a non-systemic lipidaltering drug显示文摘 | Bays H Dujovne C | 2003 | Expert Opinion on Pharmacotherapy2003，4，5： | 1 |
| 7 | Efficacy and safety of a potent new selective cholesterol absorption inhibitor,ezetimibe,in patients with primary hypercholesterolemia显示文摘 | Dujovne C A Ettinger M P Mc Neer J F | 2002 | Am J Cardiol2002，90，10： | 1 |
| 8 | Evaluation of the efficacy, safety, and tolerability of ezemitibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase Ⅲ clinical studies显示文摘 | Knopp RH Dujovne CA Le Beaut A | 2003 | Int J Clin Pract2003，57，5： | 1 |
| 9 | Efficacy and safety of a potent new selective cholesterol absorption inhibitor,ezetimibe,in patients with primary hypercholesterolemia显示文摘 | Dujovne C A Ettinger M P Mc Neer J F | 2002 | American Journal of Cardiology2002，，10： | 1 |
| 10 | Eficacy and safety of a potent new selective cholesterol absorption inhibitor ezetimibe, in patients with primary hypercholesterolemia 显示文摘 | Dujovne CA Ettinger MP Meneer JF | 2002 | Am J Cardiol2002，144，6： | 1 |
| 11 | Efficacy and safety of a potent new selective cholesterol absorption inhibitor,ezetimibe,in patients with primary hypercholesterolemia显示文摘 | Dujovne C A Ettinger M P Mc Neer J F | 2002 | Am J Cardiol2002，90，10： | 1 |
| 12 | The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia显示文摘 | Hunninghake DB Stein EA Dujovne CA | 1993 | N Engl J Med1993，328，： | 1 |
| 13 | Expanded clinical evaluation of lovasfin (EXCEL) study results: IV additional perspectives on the tolerability of lovastatin 显示文摘 | Dujovne CA Chremos AN Pool JL | 1991 | Am J Med1991，91，1： | 1 |
| 14 | Effects of sibutramine on body weight and serum lipids: a double-blind,randomized,placebo-controlled study in 322 overweight and obese patients with dyslipidemia显示文摘 | Dujovne CA Zavoral JH Rowe E | 2001 | Am Heart J2001，142，3： | 1 |
| 15 | Comparison of Once-Daily niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])显示文摘 | Bays HE Dujovne CA McGovern ME | | 0，，： | 1 |
| 16 | Efficacy and safety of a potent new selective cholesterol absorption inhibitor,ezetimibe,in patients with primary hypercholesterolemia显示文摘 | Dujovne CA Ettinger MP NcNeer F | 2002 | Am J Cardiol2002，90，： | 1 |
| 17 | Mechanical compatibility of noncemented hip prostheses with the human femur显示文摘 | Dujovne AR Bohyn Jd Krygier J J | 1993 | Arthroplasty1993，8，1： | 1 |
| 18 | Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461:results of a multicenter dose-ranging study显示文摘 | Dujovne C A Bays H Davidson M H | 2001 | J Clin Pharmacol2001，41，1： | 1 |
| 19 | Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia显示文摘 | Harris WS Gerrond C | 1994 | Am J Cardiol1994，74，： | 1 |
| 20 | Efficacy and safety of a potent new selective cholesterol absorption inhibitor ezetimibe,in patients with primary hypercholesterolemia 显示文摘 | Dujovne CA Ettinger MP McNeer JF | 2002 | Am J cardiol2002，9，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员